epilepsy
Also, a Thai language speech recognition AI has been deployed for screening depression in Thailand.
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.
Also, engineers from the University of Hong Kong have come up with a tiny biosensing platform for personalised health monitoring.
The company's REMI product is currently FDA cleared for in-hospital use, but Epitel plans to expand into ambulatory and in-home care.
The company's implanted product acts as a closed-loop system that monitors and responds to brain activity by automatically delivering stimulation prior to the start of a seizure.
The platform provides games, music and meditation tools.
The companies will be using DEARhealth's platform, which integrates AI into EHRs to predict health outcomes.
The clearance is a first for the relatively underserved epilepsy wearable space.
The device, called the NightWatch, has been created by a consortium of Dutch academic institutions and will be marketed by LivAssured.